Globus Medical (GMED) Short term Debt (2024)

Globus Medical's (GMED) quarterly Short term Debt came in at $443.4 million in Q4 2024, up 1.42% on a QoQ basis from $437.1 million in Q3 2024.

Globus Medical (GMED) Short term Debt (2024) Analysis & Trends

Globus Medical (GMED) has 1 years of Short term Debt data on file, last reported at $443.4 million in Q4 2024.

Quarterly Short term Debt changed N/A year-over-year to $443.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $443.4 million (changed N/A YoY) and the FY2024 annual result came in at $443.4 million, changed N/A from the prior year.
Short term Debt improved to $443.4 million in Q4 2024, from $437.1 million in the prior quarter.
In the past five years, Short term Debt ranged from a high of $443.4 million in Q4 2024 to a low of $424.0 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn
10	Globus Medical	11.70 Bn	11.11 Bn	548.17 Mn

Download Data